Opioid use often persists in workers' compensation claimants

Opioid use often persists in workers' compensation claimants

(HealthDay)—Many patients in a workers' compensation cohort have persistent opioid use, according to a study published online Oct. 26 in JAMA Network Open.

Nathan N. O'Hara, M.H.A., from the University of Maryland School of Medicine in Baltimore, and colleagues conducted a using workers' compensation claims data from Jan. 1, 2008, to Dec. 31, 2016, from the Chesapeake Employers' Insurance Co. Data were included for 9,596 workers' compensation claimants injured during the study years who filled at least one opioid prescription.

The researchers found that 28.6 percent of the participants filled an more than 90 days from their date of injury. Persistent opioid use was significantly associated with age 60 years or older (odds ratio, 1.92), crush injuries (odds ratio, 1.55), strain and sprain injuries (odds ratio, 1.54), annual income >$60,000 (odds ratio, 1.31), and concomitant diagnoses for chronic joint pain (odds ratio, 1.98). Workers with medical-only claims were significantly less likely to have persistent use at 90 days postinjury compared with workers whose claims were designated as permanent partial disability (odds ratio, 0.17).

"To curb the and prevent the untimely deaths of scores of Americans, policies to support alternative pain management therapies that minimize should be investigated, particularly for high-risk patients identified in this study with nonspecific diagnoses such as strain or sprain injuries," the authors write.

Several authors disclosed ties to Chesapeake Employers' Insurance Co., which funded the study.

More information: Abstract/Full Text

Journal information: JAMA Network Open

Copyright © 2018 HealthDay. All rights reserved.

Citation: Opioid use often persists in workers' compensation claimants (2018, November 1) retrieved 23 April 2024 from https://medicalxpress.com/news/2018-11-opioid-persists-workers-compensation-claimants.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Odds of death up with exposure to pregabalin, opioids


Feedback to editors